AAP
SBC

Arax Advisory Partners’s SBC Medical Group SBC Stock Holding History

Arax Advisory Partners’s Portfolio SBC Stock Details SBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21 Buy
+19
New +$79 ﹤0.01% 3716
2025
Q4 		– Sell
-409
Closed -$1.77K – 4606
2025
Q3 		$1.77K Buy
+409
New +$1.84K ﹤0.01% 3141

Other funds holding SBC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arax Advisory Partners's SBC Position: Q1 2026 in Review

Arax Advisory Partners opened a new position in SBC Medical Group (SBC) in Q1 2026: 19 shares worth $21. The stake represents ﹤0.01% of the portfolio and ranks #3716 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in SBC as recently as Q3 2025.

Arax Advisory Partners first reported a position in SBC in Q3 2025 and has held it in 2 quarters since. The position peaked at $1.77K in Q3 2025. 50 funds tracked by Wall St. Rank hold SBC as of Q1 2026.

  • Arax Advisory Partners held 19 shares of SBC Medical Group worth $21 as of Q1 2026.
  • SBC Medical Group was a new Arax Advisory Partners position in Q1 2026.
  • SBC Medical Group made up ﹤0.01% of Arax Advisory Partners's portfolio in Q1 2026, its #3716 holding.
  • Arax Advisory Partners first reported a position in SBC Medical Group in Q3 2025 and has held it in 2 quarters since.
  • Arax Advisory Partners's SBC Medical Group position peaked at $1.77K in Q3 2025.
  • 50 funds tracked by Wall St. Rank held SBC Medical Group as of Q1 2026.

Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.